Drugs Made In America Acquisition Corp. DMAA
We take great care to ensure that the data presented and summarized in this overview for Drugs Made In America Acquisition Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in DMAA
Top Purchases
Top Sells
About DMAA
Insider Transactions at DMAA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
SELL
Open market or private sale
|
Indirect |
5,698,363
-57.81%
|
-
|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-3.9%
|
-
|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
BUY
Open market or private purchase
|
Indirect |
400,000
+97.5%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,698,363
-57.81%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
400,000
-3.9%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400,000
+3.75%
|
-
|
|
Jan 29
2025
|
Sridhar G. Prasad Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Myron W. Shulgan Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Glenn C. Worman CFO |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Catherine Do Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
1.2M
Shares
From
6
Insiders
| Other acquisition or disposition | 400K shares |
|---|---|
| Open market or private purchase | 800K shares |
Sell / Disposition
12.2M
Shares
From
4
Insiders
| Other acquisition or disposition | 800K shares |
|---|---|
| Open market or private sale | 11.4M shares |